Orally administrable composition
An orally administrable micellar composition is provided. The composition comprises: i) at least one physiologically acceptable film forming agent in an amount ranging from about 30 to 80% by wt in a pharmaceutically acceptable aqueous solvent combined with ii) a micellar composition comprising a drug encapsulated in micelles of 50-1000 nm in size formed by micelle-forming compounds, in a pharmaceutically acceptable aqueous solvent.
1 . An orally administrable composition in the form of a wafer comprising: i) at least one physiologically acceptable film forming agent in an amount ranging from about 30 to 80% by wt in a pharmaceutically acceptable aqueous solvent combined with ii) a micellar mixture comprising a pharmaceutical agent encapsulated in micelles of 50-1000 nm in size formed by micelle-forming compounds, in a pharmaceutically acceptable aqueous solvent, wherein the at least one physiologically acceptable film forming agent comprises pullulan, and the micellar mixture comprises two or more micelle-forming compounds selected from the group consisting of an alkali metal alkyl sulfate, a phospholipid, a bile acid or salt thereof, glycerine and a polyoxyethylene ether, ester or alcohol.
2 . The orally administrable composition of claim 1 , wherein the composition further comprises one or more micelle-forming compounds selected from the group consisting of cholic acid, deoxycholic acid, glycocholic acid, chenodeoxycholic acid, taurocholic acid, glycodeoxycholic acid, taurodeoxycholic acid, lecithin, hyaluronic acid, pharmaceutically acceptable salts of hyaluronic acid, octylphenoxypolyethoxyethanol, glycolic acid, lactic acid, oleic acid, linoleic acid, linolenic acid, monoolein, monooleates, monolaurates, borage oil, evening of primrose oil, chamomile extract, cucumber extract, menthol, trihydroxy oxo cholanylglycine, polyglycerin, lysine, polylysine, triolein, polidocanol alkyl ethers, and mixtures thereof.
3 . The orally administrable composition of claim 1 , wherein each micelle-forming compound, and an isotonic agent, are present in an amount in the range of from 1 to 10 wt./wt. % of the total composition, and the total amount of the micelle-forming compounds and isotonic agent is less than 50 wt./wt. % of the composition.
4 . The orally administrable composition of claim 1 , wherein the at least one physiologically acceptable film forming agent additionally comprises a film forming agent selected from the group consisting of methyl cellulose, ethyl cellulose, sodium carboxymethyl cellulose, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, polyvinyl pyrrolidone, methacrylic acid polymers, methacrylic acid copolymers, acrylic acid polymers, acrylic acid copolymers, polyacrylamides, polyalkylene oxides, carrageanan, polyvinyl alcohol, sodium alginate, polyethylene glycol, polyacrylic acid, glycolide, polylactide, methylmethacrylate copolymer, carboxyvinyl polymer, amylose, high amylose starch, hydroxypropylated high amylose starch, alginic acid, pea starch, dextrin, pectin, chitin, chitosan, levan, elsinan and mixtures thereof.
5 . The orally administrable composition of claim 1 , comprising a secondary film forming agent selected from the group consisting of xanthan gum, tragacanth gum, guar gum, locust bean gum, acacia gum, arabic gum, collagen, gelatin, zein, gluten, soy protein isolate, whey protein isolate, casein and mixtures thereof.
6 . The orally administrable composition of claim 1 , wherein the at least one physiologically acceptable film forming agent comprises a mixture of pullulan with one or more other film forming agents selected from the group consisting of polyvinyl alcohol, carrageenan, guar gum, xanthan gum and locust bean gum.
7 . The orally administrable composition of claim 1 , additionally comprising one or more adjuvants selected from the group consisting of: a plasticizing agent, a flavoring agent, a sulfur precipitating agent, a saliva stimulating agent, a cooling agent, a surfactant, a stabilizing agent, an emulsifying agent, a thickening agent, a binding agent, a coloring agent, a sweetener, and a fragrance.
8 . The orally administrable composition of claim 1 , wherein the micelles are of a size within the range of about 50 to 500 nm.
9 . The orally administrable composition of claim 1 , wherein the phospholipid is phosphatidylcholine.
10 . The orally administrable composition of claim 1 , wherein the pharmaceutical agent is nicotine.
11 . The orally administrable composition of claim 10 , wherein the nicotine is synthetic nicotine.
12 . The orally administrable composition of claim 1 , wherein the pharmaceutical agent is caffeine.
13 . The orally administrable composition of claim 1 , additionally comprising one or more vitamins, minerals, nutraceuticals, or dietary supplements.
14 . The orally administrable composition of claim 1 , additionally comprising at least one vitamin.
15 . The orally administrable composition of claim 1 , wherein the pharmaceutical agent is a vitamin.
16 . The orally administrable composition of claim 1 , wherein the micellar mixture comprises an alkali metal alkyl sulfate, a phospholipid and glycerine.
17 . The orally administrable composition of claim 16 , wherein the micellar mixture additionally comprises a polyoxyethylene ether, ester or alcohol.